Sources: Teichman et al., JCEM 2006 | Raun et al., Eur J Endocrinol 1998 | Alba et al., Am J Physiol 2006 Security Profile & Chemical Identity Molecular specifications of the two peptides and documented hormonal selectivity Chemical Identity Pre-formulated Mix Two complementary peptides targeting distinct receptors for synergistic GH stimulation Documented Hormonal Selectivity Profile verified in human clinical trials Key benefit of this combination Published Clinical Data Key studies on each component and the synergy of GHRH + GHRP 2-10x Dose-dependent increase in plasma GH (30-60 g/kg SC) Results CJC-1295 (days 28 and 49) Selective First GH secretagogue without raising cortisol, prolactin or ACTH levels Selectivity vs
by using the National Health Insurance (NHI) reimbursement databases of Taiwan showed that rosiglitazone use may reduce the risk of TC in patients with T2DM (Tseng, 2013)
To further examine C1-27 selectivity and to detect other possible targets, we synthesized a fluorescent BODIPY conjugate of a C1-27 analogue
dyslipidemia, increasing the risk of atherosclerosis and cardiovascular events
PlexusDx patients can apply HSA and FSA funds at checkout without insurance involvement
At week 52, the difference in HbA 1c reduction from baseline between TRESIBA and insulin glargine U-100 was 0.08% with a 95% confidence interval of [0.05%